Non-GAAP earnings per share were $3.41.
Non-GAAP earnings per share was $3.41 with roughly 49.8 million average shares outstanding.
Non-GAAP earnings per share is expected to range from $3.24 to $3.44.
Specific to Q4, consolidated revenues are expected to range from $730 million to $760 million, up 7% to 11% in constant currency, with CooperVision revenues between $540 million and $560 million up 6% to 10% in constant currency, and CooperSurgical revenues between $190 million and $200 million, up 8.5% to 14% in constant currency.
